Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells

Circulation

Volumn 101, Issue 19, 2000, Pages 2317-2324

  Kwak, Hee Jin ^a   Lee, Song Jae ^b   Lee, Yeun Hee ^a   Ryu, Chul Hee ^a   Koh, Keum Nim ^a   Choi, Ha Young ^a   Koh, Gou Young ^a,c  

^a Chonbuk National University   (South Korea)

^b Sohae College   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

Angiopoietin; Apoptosis; Cells; Endothelium; Mannitol; Radiation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOPOIETIN 1; BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIN 1; MANNITOL; VASCULOTROPIN; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

EID: 0009587472     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.19.2317     Document Type: Article

References (32)

1. Warren JB. The Endothelium: An Introduction to Current Research. New York, NY: Wiley-Liss, Inc; 1990.
2. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev. 1990;70:427-451.
3. Leimgruber PP, Roubin GS, Hollman J, et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation. 1986;73:710-717.
4. Weinberger J, Simon AD. Intracoronary irradiation for prevention of restenosis. Curr Opin Cardiol. 1997;12:468-474.
5. Fuks Z, Persaud RS, Alfieri A, et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 1994;54:2582-2590.
6. Wiedermann JG, Leavy JA, Amols H, et al. Effects of high-dose intracoronary irradiation on vasomotor function and smooth muscle histopathology. Am J Physiol. 1994;267:H125-H132.
7. Brenner DJ, Miller RC, Hall EJ. The radiobiology of intravascular irradiation. Int J Radiat Oncol Biol Phys. 1996;36:805-810.
8. Bullock R, Chestnut RM, Clifton G, et al. Guidelines for the management of severe head injury. Brain Trauma. 1996;13:639-734.
9. Better OS, Rubinstein I, Winaver JM, et al. Mannitol therapy revisited 1940-1997. Kidney Int. 1997;52:886-894.
10. Malek AM, Goss GG, Jiang L, et al. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke. 1998;29:2631-2640.
11. Gerber H, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins bcl-2 and A1 in vascular endothelial cells. J Biol Chem. 1998;273:13313-13316.
12. Shichiri M, Kato H, Marumo F, et al. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension. 1997;30:1198-1203.
13. Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor by secretion-trap expression cloning. Cell. 1996; 87:1161-1169.
14. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277: 55-60.
15. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996;87: 1171-1180.
16. Suri C, McClain J, Thursyon G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science. 1998;282:468-471.
17. Shyu KG, Manor O, Magner M, et al. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation. 1998;98: 2081-2087.
18. Koblizek TI, Weiss C, Yancopoulos GD, et al. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. 1998;8:529-532.
19. Witzenbichler B, Maisonpierre PC, Jones P, et al. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem. 1998;29:18514-18521.
20. Papapetropoulos A, Garcia-Cardena G, Dengler TJ, et al. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest. 1999;79:213-223.
21. Kwak HJ, So J-N, Lee SJ, et al. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett. 1999;448:249-253.
22. Holash J, Maisonpierre PC, Compton D, et al. Vascular cooption, regression and growth by tumors involving angiopoietins and VEGF. Science. 1999;284:1994-1998.
23. Merrick AF, Shewring LD, Cunningham SA, et al. Organ culture of arteries for experimental studies of vascular endothelium in situ. Transplant Immunol. 1997;5:3-9.
24. Risau W. Differentiation of endothelium. FASEB J. 1995;9:926-933.
25. Teirstein PS, Massullo V, Jani S, et al. Two-year follow-up after catheter-based radiotherapy to inhibit coronary stenosis. Circulation. 1999;99:243-247.
26. Asahara T, Bauters C, Pastore BS, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793-2801.
27. Paczynski RP, HE YY, Diringer MN, et al. Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. Stroke. 1997;28:1437-1444.
28. Shapiro L, Dinarello CA. Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp Cell Res. 1997;231:354-362.
29. Kondos CD, Stauffer TP, Yang WP, et al. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol. 1998;18:4131-4140.
30. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res. 1998;82:1111-1129.
31. Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. J Biol Chem. 1988;273: 30336-30343.
32. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4-25.